Brett Losen

Senior Operations Manager @GC Therapeutics

GC Therapeutics is the first genome-wide cell landscape exploration company using an integrated synthetic biology and AI-driven platform for cell programming. Its patent-pending and proprietary pluripotent stem cell differentiation technology platform TFomeTM was developed in Professor George Church’s lab, a pioneer in synthetic biology, and allows for the development of unique cell therapies with significantly streamlined manufacturing, improved cell quality, efficiency and speed. As Senior Operations Manager, I am responsible for leading key functions of the company in a highly dynamic environment. Working directly with the CEO and CSO, my role oversees many business and laboratory needs involved with the day-to-day operations of an early stage startup.